DNA Brands, Inc. (DNAX)

DNA Brands Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	0.25	0.02	-	-	-
Revenue Growth (YoY)	1278.20%	-	-	-	-
Gross Profit	0.25	0.02	-	-	-
Selling, General & Admin	0.49	0.19	0.26	0.31	0.32
Operating Expenses	0.49	0.2	0.26	0.31	0.32
Operating Income	-0.24	-0.18	-0.26	-0.31	-0.32
Interest Expense	-	-	-0.16	-	-
Other Non Operating Income (Expenses)	-	-	-0.05	-	-
EBT Excluding Unusual Items	-0.24	-0.18	-0.46	-0.31	-0.32
Gain (Loss) on Sale of Investments	-1	-	-	-	-
Gain (Loss) on Sale of Assets	-0	-	-	-	-
Pretax Income	-1.25	-0.18	-0.46	-0.31	-0.32
Net Income	-1.25	-0.18	-0.46	-0.31	-0.32
Net Income to Common	-1.25	-0.18	-0.46	-0.31	-0.32
Shares Outstanding (Basic)	4	-	0	0	-
Shares Outstanding (Diluted)	4	-	0	0	-
Shares Change (YoY)	-	-	31.38%	-	-
EPS (Basic)	-0.28	-	-11.83	-10.59	-
EPS (Diluted)	-0.28	-	-11.83	-10.59	-
Free Cash Flow	-1.1	-0.06	-0.01	-0.11	-0.04
Free Cash Flow Per Share	-0.24	-	-0.19	-3.62	-
Gross Margin	100.00%	100.00%	-	-	-
Operating Margin	-97.80%	-999.67%	-	-	-
Profit Margin	-500.16%	-999.67%	-	-	-
Free Cash Flow Margin	-439.92%	-341.27%	-	-	-
EBITDA	-0.24	-0.18	-	-	-
EBITDA Margin	-96.25%	-	-	-	-
D&A For EBITDA	0	0.01	-	-	-
EBIT	-0.24	-0.18	-0.26	-0.31	-0.32
EBIT Margin	-97.80%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.